The lipoprotein lipase (Asn291 → Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia

Atherosclerosis

Volumn 119, Issue 2, 1996, Pages 159-167

  Hoffer, Mariëtte J V ^a   Bredie, Sebastian J H ^b   Boomsma, Dorret I ^c   Reymer, Paul W A ^d   Kastelein, Johannes J P ^d   De Knijff, Peter ^a   Demacker, Pierre N M ^b   Stalenhoef, Anton F H ^b   Havekes, Louis M ^e   Frants, Rune R ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e TNO   (Netherlands)

Author keywords

Cholesterol; Familial combined hyperlipidaemia; Lipoprotein lipase; LPL(Asn291 Ser) mutation; Triglycerides

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; ENZYME ACTIVITY; FAMILIAL HYPERLIPEMIA; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; PEDIGREE ANALYSIS; PRIORITY JOURNAL;

BASE SEQUENCE; CHOLESTEROL; CORONARY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LIPIDS; LIPOPROTEIN LIPASE; MALE; MOLECULAR SEQUENCE DATA; NETHERLANDS; PEDIGREE; POINT MUTATION; PREVALENCE; RISK FACTORS; TRIGLYCERIDES;

EID: 0030032347     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05641-6     Document Type: Article

References (31)

1. Goldstein JL. Schrott HG. Hazzard WR. Bierman HL Motulsky GA. II. Genetic analysis of lipid levels in 176 families and delineation of new inherited disorder, combined hyperlipidaemia. J Clin Invest 1973;52:1544.
2. Grundy SM, Chait A, Brunzell JD. Familial combined hyperlipidaemia workshop. Arteriosclerosis 1987;7:203.
3. Kwiterovich PO Jr, White S, Forte T, Bachorik PS Smith H. Sniderman A. Hyperabetalipoproteinemia in a kindred with familial combined hyperlipidaemia and familial hypercholesterolemia. Arteriosclerosis 1987;7:211.
4. Austin MA, Brunzell JD, Fitch WL, Krauss RM. Inheritance of low density lipoprotein subclass phenotypes in familial combined hyperlipidaemia. Arteriosclerosis 1990;10:520.
5. Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME. Lalouel J-M, Williams RR. Apolipo-protein. low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidaemia. Arteriosclerosis 1989;9:335.
6. Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E McDonald GB. Plasma lipoproteins in familial combined hyperlipidaemia and monogenic familial hypertriglyceridemia. J Lipid Res 1980;24:147.
7. Cullen P, Farren B, Scott J, Farraall M. Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 british families with familial combined hyperlipidaemia. Arterioscler Thromb 1994;14:1233.
8. Kwiterovich PO. Genetics and molecular biology of familial combined hyperlipidaemia. Curr Opin Lipidol 1993;4:133.
9. Austin MA, Horowitz H. Wijsman E, Krauss RM, Brunzell JD. Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidaemia. Atherosclerosis 1992;92:67.
10. Wojchiechowski AP. Farrall M, Cullen P, Wilson TME Bayliss JD, Farren B, Griffin BA, Caslake MJ, Packard CJ Shepherd J. Thakker R. Scott J. Familial combined hyperlipidaemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23-q24. Nature 1991;349:161.
11. Nishina PM, Johnson JP, Naggert JK, Krauss RM. Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Proc Natl Acad Sci USA 1992;89:708.
12. Babirak SP, Ivenus P-H, Fujimoto WY, Brunzell JD. Deletion and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 1989;9:326.
13. Babirak SP, Brown BG, Brunzell JD. Familial combined hyperlipidaemia and abnormal lipoprotein lipase. Arterioscler Thromb 1992;12:1176.
14. Reymer PWA. Gagné E, Groenemeyer BE, Ma Y, Appleman EEG. van der Oever K, Bruin T, Seidel JC, Kastelein JJP. Hayden MR. A mutation (N291S) in the LPL gene occurs with increased frequency in patients with premature atherosclerosis and hyperlipidaemia. Circulation 1994;90:I-998 (Abstract).
15. Miller SA, Dykes DD. Polesky HF. A simple salting out procedure for extracting DNA from nucleated cells. Nucl Acid Res 1988;16:1215.
16. Demacker PNM, Vos-Janssen HE, Jansen AP, van 't Laar A. Evaluation of the dual-precipitation method by comparison with the ultracentrifugation method for measurement of lipoproteins in serum. Clin Chem 1977;23:1238.
17. Demacker PNM, Hijmans AG, Vos-Janssen HE, van't Laar A, Jansen AP. A study of the use of polyethylene glycol in estimating cholesterol in high density lipoprotein. Clin Chem 1980;26:1775.
18. Friedewald WT, Levy R, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499.
19. Wion KL, Kichgessner TG. Lusis AJ, Schotz MC, Lawn RM. Human lipoprotein lipase complementary DNA sequence. Science 1987;235:1638.
20. Lange K, Weeks K, Boehnke M. Programs for pedigree analysis: MENDEL, FISHER and dGENE. Genet Epidemiol 1988;5:471.
21. Lange K, Westlake J, Spence MA. Extensions to pedigree analysis III. Variance components by the scoring method. Ann Hum Genet 1976;39:485.
22. Ma Y, Ooi TC, Liu M-S. Zhang H, McPherson R, Edwards AL, Forsythe IJ. Frohlich J, Brunzell JD, Hayden MR. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. J Lipid Res 1994;35:1066.
23. Reilly SL, Kottke BA, Sing CF. The effects of generation and gender on the joint distributions of lipid and apolipoprotein phenotypes in the population at large. J Clin Epidemiol 1990;43:921.
24. Hamsten A, Iselius L. Dahlén G, de Faire U. Genetic and cultural inheritance of serum lipids, low and high density lipoprotein cholesterol and serum apolipoproteins A-I, A-II, and B. Atherosclerosis 1986;60:199.
25. Reymer P, Gagné E, Groenemeyer BE, Forsyth IJ, Jansen H. Seidell JC, Lie KI. Zhang H, Kastelein JJP, Hayden MR. An Asn291Ser mutation in the human lipoprotein lipase is associated with reduced HDL levels in patients with premature atherosclerosis. Nat Genet 1995;10:28.
26. Wilson DA, Emi M, Iverius P-H, Hata A, Wu LL, Hillas E, Williams RR, Lalouel J-M. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest 1990;86:735.
27. Miesenböck G, Hölz B, Föger B, Brandstätter E Paulweber B, Sandhofer F, Patch JR. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest 1993;91:448.
28. Funke H, Assmann G. The lowdown on lipoprotein lipase. Nat Genet 1995;10:6.
29. Nevin DN, Brunzell JD, Deeb SS, The LPL gene in individuals with familial combined hyperlipidaemia and decreased LPL activity. Arterioscler Thromb 1994;14:869.
30. Gagné E, Genest J Jr, Zhang H, Clarke LA, Hayden MR. Analysis of DNA changes in the LPL gene with familial combined hyperlipidaemia. Arterioscler Thromb 1994; 14:1250.
31. Mailly F, Tugrul Y, Reymer PWA, Bruin T, Seed M Groenemeyer BF, Asplund-Carlson A, Vallance D, Winder AF, Miller GJ, Kastelein JJP, Hamsten A, Olivecrona G, Humphries SE, Talmud PJ. A common variant in the gene for lipoprotein lipase (Asp9 → Asn). Arterioscler Thromb Vase Biol 1995;15:468.